Blackfoot disease in Taiwan: Its link with inorganic arsenic exposure from drinking water

Ambio

Volumn 36, Issue 1, 2007, Pages 82-84

  Tseng, Chin Hsiao ^a,b   Chong, Choon Khim ^c   Tseng, Ching Ping ^e   Centeno, Jose A ^d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^e Department of Environmental and Infectious Disease Sciences ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC;

ARSENIC; DISEASE; DRINKING WATER; INORGANIC COMPOUND; POLLUTION EFFECT; POLLUTION EXPOSURE;

CHEMICALLY INDUCED DISORDER; ENVIRONMENTAL EXPOSURE; HUMAN; MORTALITY; PATHOLOGY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; SHORT SURVEY; TAIWAN; WATER SUPPLY;

ARSENIC; ENVIRONMENTAL EXPOSURE; HUMANS; PERIPHERAL VASCULAR DISEASES; PREVALENCE; TAIWAN; WATER SUPPLY;

ASIA; EURASIA; FAR EAST; TAIWAN;

EID: 34247121539     PISSN: 00447447     EISSN: None     Source Type: Journal    
DOI: 10.1579/0044-7447(2007)36[82:BDITIL]2.0.CO;2     Document Type: Short Survey

References (29)

1. Tseng, W.P. 1989. Blackfoot disease in Taiwan: A 30-year follow-up study. Angiology 40, 547-558.
2. Tseng, C.H. 2002. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 53, 529-537.
3. Tseng, C.H. 2005. Blackfoot disease and arsenic: a never-ending story. J. Environ. Sci. Health C 23, 55-74.
4. Kuo, T.L. 1964. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Rep. Inst. Pathol. Taipei Taiwan Natl. Taiwan Univ. Coll. Med. 20, 7-13.
5. Chen, K.P., Wu, H.Y. and Wu, T.C. 1962. Epidemiologic studies on blackfoot disease in Taiwan: III. Physicochemical characteristics of drinking water in endemic blackfoot disease areas. Mem. Coll. Med. Natl. Taiwan Univ. 8, 115-129.
6. Tseng, C.H., Chen, C.J., Lin, B.J. and Tai, T.Y. 1994. Abnormal response of ankle pressure after exercise in seemingly normal subjects living in blackfoot disease-hyperendemic villages in Taiwan. Vasc. Surg. 28, 607-617.
7. Tseng, C.H., Tai, T.Y., Lin, B.J. and Chen, C.J. 1995. Abnormal peripheral microcirculation in seemingly normal subjects living in blackfoot disease-hyperendemic villages in Taiwan. Int. J. Microcirc. 5, 21-27.
8. Tseng, C.H., Chong, C.K., Chen, C.J. and Tai, T.Y. 1996. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 20, 125-133.
9. Tseng, C.H., Chong, C.K., Chen, C.J. and Tai, T.Y. 1997. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan. Angiology 48, 321-335.
10. Tseng, C.H., Huang, Y.K., Huang, Y.L., Chung, C.J., Yang, M.H., Chen, C.J. and Hsueh, Y.M. 2005. Arsenic exposure, urinary arsenic speciation and peripheral vascular disease in blackfoot disease hyperendemic villages in Taiwan. Toxicol. Appl. Pharmacol. 206, 299-308.
11. Tseng, W.P., Chu, H.M., How, S.W., Fong, J.M., Lin, C.S. and Yeh, S. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40, 453-463.
12. Tseng, C.H. 2003. Abnormal current perception thresholds measured by Neurometer among residents in blackfoot disease hyperendemic villages in Taiwan. Toxicol. Lett. 146, 27-36.
13. Yang, C.Y. 2006. Does arsenic exposure increase the risk of development of peripheral vascular diseases in humans? J. Toxicol. Environ. Health A 69, 1797-1804.
14. Tseng, C.H., Chong, C.K., Tseng, C.P., Hsueh, Y.M., Chiou, H.Y., Tseng, C.C. and Chen, C.J. 2003. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol. Lett. 137, 15-21.
15. Sedman, R.M., Beaumont, J., McDonald, T.A., Reynolds, S., Krowech, G. and Howd, R. 2006. Review of the evidence regarding the carcinogenicity of hexavalent chromium in drinking water. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 24, 155-182.
16. Ahmed, F.E. 2006. Gene-gene, gene-environment and multiple interactions in colorectal cancer. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 24, 1-101.
17. Thorpe, N. and Shirmohammadi, A. 2005. Herbicides and nitrates in groundwater of Maryland and childhood cancers: a geographic information systems approach. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 23, 261-278.
18. Clark, H.A. and Snedeker, S.M. 2005. Critical evaluation of the cancer risk of dibromochloropropane (DBCP). J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 23, 215-260.
19. McDonald, T.A. and Komulainen, H. 2005. Carcinogenicity of the chlorination disinfection by-product MX. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 23, 163-214.
20. Yang, M. and Pyo, M.Y. 2005. Molecular epidemiology of lung cancer in female passive smokers. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 23, 75-97.
21. Fukushima, S., Morimura, K., Wanibuchi, H., Kinoshita, A. and Salim, E.I. 2005. Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens. Toxicol. Appl. Pharmacol. 207, (2 Suppl), 225-229.
22. Wanibuchi, H., Salim, E.I., Kinoshita, A., Shen, J., Wei, M., Morimura, K., Yoshida, K., Kuroda, K. et al. 2004. Understanding arsenic carcinogenicity by the use of animal models. Toxicol. Appl. Pharmacol. 198, 366-376.
23. Mizoi, M., Takabayashi, P., Nakano, M., An, Y., Sagesaka, Y., Kato, K., Okada, S. and Yamanaka, K. 2005. The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress. Toxicol Lett. 158, 87-94.
24. Basu, A., Som, A., Ghoshal, S., Mondal, L., Chaubey, R.C. Bhilwade, H.N., Rahman, M.M. and Giri, A.K. 2005. Assessment of DNA damage in peripheral blood lymphocytes of individuals susceptible to arsenic induced toxicity in West Bengal, India. Toxicol. Lett. 159, 100-112.
25. Tseng, C.H. 2004. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol. Appl. Pharmacol. 197, 67-83.
26. Tseng, C.H., Tseng, C.P., Chiou, H.Y., Hsueh, Y.M., Chong, C.K. and Chen, C.J. 2002. Epidemiologic evidence of diabetogenic effect of arsenic. Toxicol. Lett. 133, 69-76.
27. Tseng, C.H., Tai, T.Y., Chong, C.K., Tseng, C.P., Lai, M.S., Lin, B.J., Chiou, H.Y., Hsueh, Y.M. et al. 2000. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ. Health Perspect. 108, 847-851.
28. Chen, C.J., Hsueh, Y.M., Lai, M.S., Shyu, M.P., Chen, S.Y., Wu, M.M., Kuo, T.L. and Tai, T.Y. 1995. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25, 53-60.
29. The authors thank the Department of Health (DOH89-TD-1035) and the National Science Council (NSC-90-2320-B-002-197. NSC-92-2320-B-002-156, NSC-93 2320-B-002-071, NSC-94 2314-B-002-142, and NSC-95-2314-B-002-311) of Taiwan for their continuous financial support for epidemiological studies on arsenic-related health hazards and diabetes mellitus carried out in Taiwan.